Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22753915 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC
Condition: Non-small-cell Lung Cancer
Intervention: Drug: Gefitinib

Study has passed its completion date and status has not been verified in more than two years.